|
UHRF1BP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.874000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.650800E-01 |
| Normal-vs-Stage2 |
1.139760E-01 |
| Normal-vs-Stage3 |
2.923000E-01 |
| Normal-vs-Stage4 |
7.273400E-01 |
| Stage1-vs-Stage2 |
3.553900E-02 |
| Stage1-vs-Stage3 |
2.015600E-01 |
| Stage1-vs-Stage4 |
5.347000E-01 |
| Stage2-vs-Stage3 |
7.422200E-01 |
| Stage2-vs-Stage4 |
4.807200E-01 |
| Stage3-vs-Stage4 |
7.204400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.325000E-01 |
| Normal-vs-AfricanAmerican |
1.182230E-01 |
| Normal-vs-Asian |
7.968000E-01 |
| Caucasian-vs-AfricanAmerican |
1.709990E-01 |
| Caucasian-vs-Asian |
8.508000E-01 |
| AfricanAmerican-vs-Asian |
7.678600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.350200E-01 |
| Normal-vs-Female |
2.538100E-03 |
| Male-vs-Female |
3.042800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.569000E-01 |
| Normal-vs-Extreme_Weight |
4.735600E-02 |
| Normal-vs-Obese |
1.029420E-01 |
| Normal-vs-Extreme_Obese |
7.801600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.170800E-01 |
| Normal_Weight-vs-Obese |
1.824770E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.360800E-01 |
| Extreme_Weight-vs-Obese |
1.058070E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.040000E-01 |
| Obese-vs-Extreme_Obese |
1.552190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.566200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.046200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.369200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.651440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.071800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.923900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.898200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.574100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.395700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.854200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.502200E-01 |
| Normal-VS-Type2 PRCC |
7.892800E-01 |
| Normal-VS-KIRP CIMP |
4.425800E-02 |
| Normal-VS-Unclassified PRCC |
1.380200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.840000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.036100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.320100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.772200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.241200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.414000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.816800E-01 |
| Normal-vs-N1 |
8.187800E-02 |
| Normal-vs-N2 |
9.915200E-01 |
| N0-vs-N1 |
4.772000E-02 |
| N0-vs-N2 |
7.236400E-01 |
| N1-vs-N2 |
4.744800E-01 |
|
|
